Singapore markets open in 4 hours 43 minutes

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3300+0.0600 (+2.64%)
As of 03:11PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 138.26M
Enterprise value -88.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.52
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.54

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 3-71.05%
S&P500 52-week change 3-7.75%
52-week high 38.4200
52-week low 31.3500
50-day moving average 31.9695
200-day moving average 33.4339

Share statistics

Avg vol (3-month) 3288.89k
Avg vol (10-day) 3309.98k
Shares outstanding 556.9M
Implied shares outstanding 6N/A
Float 843.47M
% held by insiders 115.50%
% held by institutions 163.84%
Shares short (12 Jan 2023) 43.56M
Short ratio (12 Jan 2023) 49.31
Short % of float (12 Jan 2023) 48.46%
Short % of shares outstanding (12 Jan 2023) 46.26%
Shares short (prior month 14 Dec 2022) 43.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.09%
Return on equity (ttm)-49.12%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -163.6M
Net income avi to common (ttm)-163.76M
Diluted EPS (ttm)-2.9230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)258.26M
Total cash per share (mrq)4.54
Total debt (mrq)31.77M
Total debt/equity (mrq)11.87
Current ratio (mrq)13.16
Book value per share (mrq)4.74

Cash flow statement

Operating cash flow (ttm)-126.92M
Levered free cash flow (ttm)-68.66M